These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15746301)

  • 21. Simultaneous quantification of mycophenolic acid and its glucuronide metabolites in human plasma by an UPLC-MS/MS assay.
    Zhang D; Chow DS; Renbarger JL
    Biomed Chromatogr; 2016 Oct; 30(10):1648-55. PubMed ID: 27061819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicriteria optimization methodology in development of HPLC separation of mycophenolic acid and mycophenolic acid glucuronide in human urine and plasma.
    Zivanović L; Protić A; Zecević M; Jocić B; Kostić M
    J Pharm Biomed Anal; 2009 Nov; 50(4):640-8. PubMed ID: 19036547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry.
    Difrancesco R; Frerichs V; Donnelly J; Hagler C; Hochreiter J; Tornatore KM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):42-51. PubMed ID: 17928278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-performance liquid chromatography determination of mycophenolic acid and its glucuronide metabolite in human plasma.
    Jones CE; Taylor PJ; Johnson AG
    J Chromatogr B Biomed Sci Appl; 1998 Apr; 708(1-2):229-34. PubMed ID: 9653967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a high pressure liquid chromatography method for the determination of mycophenolic acid and its glucuronide metabolite in small volumes of plasma from paediatric patients.
    Watson DG; Araya FG; Galloway PJ; Beattie TJ
    J Pharm Biomed Anal; 2004 Apr; 35(1):87-92. PubMed ID: 15030883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detection.
    Aresta A; Palmisano F; Zambonin CG; Schena P; Grandaliano G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):197-202. PubMed ID: 15380715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
    Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
    Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography.
    Mino Y; Naito T; Matsushita T; Kagawa Y; Kawakami J
    J Pharm Biomed Anal; 2008 Feb; 46(3):603-8. PubMed ID: 18164890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine.
    Benoit-Biancamano MO; Caron P; Lévesque E; Delage R; Couture F; Guillemette C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):159-67. PubMed ID: 17827076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants.
    Ceglarek U; Casetta B; Lembcke J; Baumann S; Fiedler GM; Thiery J
    Clin Chim Acta; 2006 Nov; 373(1-2):168-71. PubMed ID: 16806142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple HPLC method for monitoring mycophenolic acid and its glucuronidated metabolite in transplant recipients.
    Seebacher G; Weigel G; Wolner E; Mallinger R; Grimm M; Laufer G; El Menyawi I; Griesmacher A; Müller MM
    Clin Chem Lab Med; 1999 Apr; 37(4):409-15. PubMed ID: 10369111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil.
    Ling J; Shi J; Jiang Q; Jiao Z
    Eur J Clin Pharmacol; 2015 Jan; 71(1):95-106. PubMed ID: 25327506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.
    Prémaud A; Rousseau A; Le Meur Y; Lachâtre G; Marquet P
    Ther Drug Monit; 2004 Dec; 26(6):609-19. PubMed ID: 15570184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients.
    van Hest RM; van Gelder T; Vulto AG; Shaw LM; Mathot RA
    Clin Pharmacokinet; 2009; 48(7):463-76. PubMed ID: 19691368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An isocratic high performance liquid chromatographic method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid-liquid extraction: application to human pharmacokinetic studies.
    Bahrami G; Mohammadi B
    Clin Chim Acta; 2006 Aug; 370(1-2):185-90. PubMed ID: 16707117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of Mycophenolic Acid and Mycophenolic Acid Glucuronide in Serum or Plasma by LC-MS/MS.
    Garg U; Munar A; Frazee C
    Curr Protoc; 2023 Apr; 3(4):e730. PubMed ID: 37039714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ann Pharmacother; 2006 Sep; 40(9):1509-16. PubMed ID: 16882870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Liquid Chromatography-Tandem Mass Spectrometric Method for Quantification of Mycophenolic Acid and Its Glucuronides in Dried Blood Spot Samples.
    Iboshi H; Yamaguchi H; Suzuki H; Kikuchi M; Tanaka M; Takasaki S; Takahashi A; Maekawa M; Shimada M; Matsuda Y; Okada Y; Mano N
    Ther Drug Monit; 2017 Dec; 39(6):648-653. PubMed ID: 29040229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimus.
    Tedesco-Silva H; Felipe CR; Slade A; Schmouder RL; Medina Pestana JO
    Ther Drug Monit; 2012 Dec; 34(6):652-9. PubMed ID: 23131696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.